麻醉科医生如何创新:美国麻醉医师学会创新委员会的指导
本文由美国麻醉医师学会创新委员会发布,指出麻醉学创新面临监管与财务障碍,提出将Biodesign框架应用于围术期医疗技术开发。该框架从识别和筛选高价值临床需求开始,经方案生成与评估,最终形成策略、商业计划与融资,引导临床医生将观察转化为可行技术。
要点
- Biodesign框架可系统指导围术期技术创新。
- 创新始于识别和筛选高价值临床需求。
- 最终需完成策略开发、商业计划与融资。
核心结论
- 采用Biodesign结构化方法,麻醉科医生可将临床洞察转化为可扩展的创新解决方案。
研究设计与样本
- 美国麻醉医师学会创新委员会发布的指导性文件,介绍Biodesign框架在围术期创新中的应用。
主要发现
- 当代麻醉科医生面临日益增长的监管要求和财务限制等创新障碍。
- Biodesign框架包括识别和筛选高价值临床需求、生成和评估潜在解决方案、策略开发与商业计划及融资等阶段。
关键数值与推荐
- 创新过程始于识别和筛选高价值临床需求。
- 随后生成和评估潜在解决方案。
- 最终进行策略开发、商业计划和融资。
临床怎么用
- 麻醉科医生可按照Biodesign框架系统推进围术期技术创新。
- 从临床观察出发,经过需求筛选和方案评估,最终实现技术转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While the field of anesthesiology has a storied history of innovation, especially related to patient safety, contemporary anesthesiologists face growing barriers to innovation from complex regulatory requirements and financial constraints. The Biodesign framework offers a systematic approach to medical technology development that can be applied to the perioperative space to address these challenges. This process begins with identification and screening of high-value clinical needs, followed by generation and evaluation of potential solutions, and culminates in strategy development, business planning, and fundraising. Each stage is designed to guide clinicians from early observation through translation into viable technologies. By adopting this structured method, anesthesiologists are well-positioned to transform clinical insights into scalable solutions, ensuring the specialty continues to advance patient safety and care in the face of evolving clinical demands.
引用
- Rens NE, Smischney NJ, Huang J, et al. How to Innovate as an Anesthesiologist: Guidance From the American Society of Anesthesiologists Committee on Innovation. Anesth Analg. 2026. PMID: 42148767. doi:10.1213/ANE.0000000000008075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。